GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 55 filers reported holding GAMIDA CELL LTD in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | -99.9% | 32,545 | +2.0% | 0.00% | -40.0% |
| Q3 2022 | $51,000 | +41.7% | 31,922 | +57.6% | 0.01% | +66.7% |
| Q2 2022 | $36,000 | -77.2% | 20,255 | +3.5% | 0.00% | -72.7% |
| Q1 2021 | $158,000 | -44.4% | 19,574 | -42.2% | 0.01% | -64.5% |
| Q4 2020 | $284,000 | +246.3% | 33,887 | +70.5% | 0.03% | +121.4% |
| Q3 2020 | $82,000 | – | 19,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |